Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocktail Therapy for Clinical Cure of Chronic Hepatitis B
ChiCTR2100046743Phase 4Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tenofovir in Chronic Hepatitis B (CHB) (3 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoint: HBsAg seroconversion rate. Started Jun 2021; status: recruiting.
02
Drugs
tenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2100046743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046743.